Seham A. Abd El-Aleem
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Seham A. Abd El-Aleem has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
Entesar Ali Saber
Department of Histology and Cell Biology Minia University Minya Egypt
3 shared publicationsHanaa Hassanein Mohammed
Minia Univ, Dept Histol & Cell Biol, Al Minya, Egypt
3 shared publicationsIan Appleton
Pharmacology Department, University of Otago, Dunedin, New Zealand
3 shared publications- Laiche Djouhri
Department of Basic Medical Sciences, College of Medicine, QU Health, Qatar University, Doha, Qatar
3 shared publications - Lucy Frances Donaldson
School of Life Sciences, The Medical School QMC, University of Nottingham, UK
3 shared publications Asad Zeidan
Department of Basic Medical Sciences, College of Medicine, QU Health, Qatar University, P.O. Box 2713, Doha, Qatar
2 shared publications
Latest Publications
- 1 December 2023
- Published by Egyptian Knowledge Bank in Journal of Medical Histology
- Vol. 7 (2) , 144-184
Mesenchymal Stem Cell-Derived Exosomes Versus its Conditioned Medium in Amelioration of Hippocampal Rat Model of Alzheimer's Disease, Behavioral, Biochemical, Histological and Immunohistochemical Study
Introduction: Alzheimer's disease is the most common form of dementia. Recently, mesenchymal stem cells-conditioned medium and exosomes have lately been employed in several therapeutic investigations. Aim of work: To demonstrate hippocampus’s biochemical, histological, and immunohistochemical changes in albino rats after induction of Alzheimer and to evaluate the role of mesenchymal stem cells-conditioned medium versus exosomes on the albino rat Alzheimer model. Materials and Methods: Thirty-two rats were used in this study plus ten rats were used in the preparation of mesenchymal stem cells derived conditioned media and exosomes. Rats were divided into four groups; Control, Alzheimer group, Conditioned media, and Exosome treated group. Behavioral tests were performed. The hippocampi were prepared for biochemical, histological, and immunohistochemical study. Results: The Alzheimer group showed various behavioral changes. Rats also showed significant changes in hippocampal malondialdehyde, tumor necrotic factor, total antioxidant capacity, acetylcholine esterase, and monoamine oxidase. Microscopically, hippocampi showed degenerated neurons as well as argyrophilic neurofibrillary tangles and amyloid plaque formation. The conditioned medium and exosomes treated groups displayed biochemical, functional and structural improvement with reduced argyrophilic neurofibrillary tangles and amyloid plaque formation. Treatment with exosomes was superior to conditioned medium as they improved neuronal function, regulated astrocyte and microglial activities, and enhanced regenerative changes. Conclusion: The conditioned medium and exosomes minimized Alzheimer -hippocampal associated biochemical, histological, and immunohistochemical degenerative changes with better effect with exosome treatment. These results may pave the future for using exosomes as an effective adjuvant therapy in Alzheimer patients.
- 1 December 2023
- Published by Egyptian Knowledge Bank in Journal of Medical Histology
- Vol. 7 (2) , 144-184
Mesenchymal Stem Cell-Derived Exosomes Versus its Conditioned Medium in Amelioration of Hippocampal Rat Model of Alzheimer's Disease, Behavioral, Biochemical, Histological and Immunohistochemical Study
Introduction: Alzheimer's disease is the most common form of dementia. Recently, mesenchymal stem cells-conditioned medium and exosomes have lately been employed in several therapeutic investigations. Aim of work: To demonstrate hippocampus’s biochemical, histological, and immunohistochemical changes in albino rats after induction of Alzheimer and to evaluate the role of mesenchymal stem cells-conditioned medium versus exosomes on the albino rat Alzheimer model. Materials and Methods: Thirty-two rats were used in this study plus ten rats were used in the preparation of mesenchymal stem cells derived conditioned media and exosomes. Rats were divided into four groups; Control, Alzheimer group, Conditioned media, and Exosome treated group. Behavioral tests were performed. The hippocampi were prepared for biochemical, histological, and immunohistochemical study. Results: The Alzheimer group showed various behavioral changes. Rats also showed significant changes in hippocampal malondialdehyde, tumor necrotic factor, total antioxidant capacity, acetylcholine esterase, and monoamine oxidase. Microscopically, hippocampi showed degenerated neurons as well as argyrophilic neurofibrillary tangles and amyloid plaque formation. The conditioned medium and exosomes treated groups displayed biochemical, functional and structural improvement with reduced argyrophilic neurofibrillary tangles and amyloid plaque formation. Treatment with exosomes was superior to conditioned medium as they improved neuronal function, regulated astrocyte and microglial activities, and enhanced regenerative changes. Conclusion: The conditioned medium and exosomes minimized Alzheimer -hippocampal associated biochemical, histological, and immunohistochemical degenerative changes with better effect with exosome treatment. These results may pave the future for using exosomes as an effective adjuvant therapy in Alzheimer patients.
- 15 September 2022
- Published by Elsevier in Life Sciences
- Vol. 308, 120967
Annexin A2 (AnxA2) association with the clinicopathological data in different breast cancer subtypes: A possible role for AnxA2 in tumor heterogeneity and cancer progression
- 15 September 2022
- Published by Elsevier in Life Sciences
- Vol. 308, 120967
Annexin A2 (AnxA2) association with the clinicopathological data in different breast cancer subtypes: A possible role for AnxA2 in tumor heterogeneity and cancer progression
- 17 December 2021
- Published by Wiley in Journal of Cellular Physiology
- Vol. 237 (4) , 2019-2033
Follicular dendritic cells
Follicular dendritic cells (FDCs) are unique accessory immune cells that contribute to the regulation of humoral immunity. They are multitasker cells essential for the organization and maintenance of the lymphoid architecture, induction of germinal center reaction, production of B memory cells, and protection from autoimmune disorders. They perform their activities through both antigen‐driven and chemical signaling to B cells. FDCs play a crucial role in the physiological regulation of the immune response. Dis‐regulation of this immune response results when FDCs retain antigens for years. This provides a constant antigenic stimulation for B cells resulting in the development of immune disorders. Antigen trapped on FDCs is resistant to therapeutic intervention causing chronicity and recurrences. Beyond their physiological immunoregulatory functions, FDCs are involved in the pathogenesis of several immune‐related disorders including HIV/AIDS, prion diseases, chronic inflammatory, and autoimmune disorders. FDCs have also been recently implicated in rare neoplasms of lymphoid and hematopoietic tissues. Understanding FDC biology is essential for better control of humoral immunity and opens the gate for therapeutic management of FDC‐mediated immune disorders. Thus, the biology of FDCs has become a hot research area in the last couple of decades. In this review, we aim to provide a comprehensive overview of FDCs and their role in physiological and pathological conditions.
- 17 December 2021
- Published by Wiley in Journal of Cellular Physiology
- Vol. 237 (4) , 2019-2033
Follicular dendritic cells
Follicular dendritic cells (FDCs) are unique accessory immune cells that contribute to the regulation of humoral immunity. They are multitasker cells essential for the organization and maintenance of the lymphoid architecture, induction of germinal center reaction, production of B memory cells, and protection from autoimmune disorders. They perform their activities through both antigen‐driven and chemical signaling to B cells. FDCs play a crucial role in the physiological regulation of the immune response. Dis‐regulation of this immune response results when FDCs retain antigens for years. This provides a constant antigenic stimulation for B cells resulting in the development of immune disorders. Antigen trapped on FDCs is resistant to therapeutic intervention causing chronicity and recurrences. Beyond their physiological immunoregulatory functions, FDCs are involved in the pathogenesis of several immune‐related disorders including HIV/AIDS, prion diseases, chronic inflammatory, and autoimmune disorders. FDCs have also been recently implicated in rare neoplasms of lymphoid and hematopoietic tissues. Understanding FDC biology is essential for better control of humoral immunity and opens the gate for therapeutic management of FDC‐mediated immune disorders. Thus, the biology of FDCs has become a hot research area in the last couple of decades. In this review, we aim to provide a comprehensive overview of FDCs and their role in physiological and pathological conditions.
- 1 November 2021
- Published by Elsevier in Life Sciences
- Vol. 285, 119983
Curcumin activation of nuclear factor E2-related factor 2 gene (Nrf2): Prophylactic and therapeutic effect in nonalcoholic steatohepatitis (NASH)
- 1 November 2021
- Published by Elsevier in Life Sciences
- Vol. 285, 119983
Curcumin activation of nuclear factor E2-related factor 2 gene (Nrf2): Prophylactic and therapeutic effect in nonalcoholic steatohepatitis (NASH)
- 1 October 2020
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1866 (10) , 165850
Mutual inter-regulation between iNOS and TGF-β1: Possible molecular and cellular mechanisms of iNOS in wound healing
- 1 October 2020
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1866 (10) , 165850
Mutual inter-regulation between iNOS and TGF-β1: Possible molecular and cellular mechanisms of iNOS in wound healing
- 1 September 2020
- Published by Elsevier in Neuroscience Letters
- Vol. 736, 135277
Changes in expression of Kv7.5 and Kv7.2 channels in dorsal root ganglion neurons in the streptozotocin rat model of painful diabetic neuropathy
- 1 September 2020
- Published by Elsevier in Neuroscience Letters
- Vol. 736, 135277
Changes in expression of Kv7.5 and Kv7.2 channels in dorsal root ganglion neurons in the streptozotocin rat model of painful diabetic neuropathy
- 1 September 2020
- Published by Elsevier in Journal of Chemical Neuroanatomy
- Vol. 107, 101795
Neuroprotective effect of quercetin nanoparticles: A possible prophylactic and therapeutic role in alzheimer’s disease
- 1 September 2020
- Published by Elsevier in Journal of Chemical Neuroanatomy
- Vol. 107, 101795
Neuroprotective effect of quercetin nanoparticles: A possible prophylactic and therapeutic role in alzheimer’s disease
- 27 May 2020
- Published by Wiley in Journal of Cellular Physiology
- Vol. 235 (12) , 9974-9991
A possible role for inducible arginase isoform (AI) in the pathogenesis of chronic venous leg ulcer
Chronic venous ulcer (CVU) is a major cause of chronic wounds of lower extremities and presents a significant financial and resource burden to health care systems worldwide. Defects in the vasculature, matrix deposition, and re‐epithelialization are the main histopathological changes believed to impede healing. Supplementation of the amino acid arginine that plays a crucial role in the interactions that occur during inflammation and wound healing was proven clinically to improve acute wound healing probably through enhancing activity of inducible arginase (AI) locally in the wounds. However, the possible mechanism of arginine action and the potential beneficial effects of AI/arginine in human chronic wounds remain unclear. In the present study, using biopsies, taken under local anesthesia, from adult patients (n = 12, mean age 55 years old) with CVUs in lower extremities, we investigated the correlation between AI distribution in CVUs and the histopathological changes, mainly proliferative and vascular changes. Our results show a distinct spatial distribution of AI along the ulcer in the epidermis and in the dermis with the highest level of expression being at the ulcer edge and the least expression towards the ulcer base. The AI cellular immunoreactivity, enzymatic activity, and protein levels were significantly increased towards the ulcer edge. Interestingly, a similar pattern of expression was encountered in the proliferative and the vascular changes with strong correlations between AI and the proliferative activity and vascular changes. Furthermore, AI cellular distribution was associated with increased proliferative activity, inflammation, and vascular changes. Our findings of differential expression of AI along the CVU base, edge, and nearby surrounding skin and its associations with increased proliferative activity and vascular changes provide further support to the AI implication in CVU pathogenesis. The presence of high levels of AI in the epidermis of chronic wounds may serve as a molecular marker of impaired healing and may provide future targets for therapeutic intervention.
- 27 May 2020
- Published by Wiley in Journal of Cellular Physiology
- Vol. 235 (12) , 9974-9991
A possible role for inducible arginase isoform (AI) in the pathogenesis of chronic venous leg ulcer
Chronic venous ulcer (CVU) is a major cause of chronic wounds of lower extremities and presents a significant financial and resource burden to health care systems worldwide. Defects in the vasculature, matrix deposition, and re‐epithelialization are the main histopathological changes believed to impede healing. Supplementation of the amino acid arginine that plays a crucial role in the interactions that occur during inflammation and wound healing was proven clinically to improve acute wound healing probably through enhancing activity of inducible arginase (AI) locally in the wounds. However, the possible mechanism of arginine action and the potential beneficial effects of AI/arginine in human chronic wounds remain unclear. In the present study, using biopsies, taken under local anesthesia, from adult patients (n = 12, mean age 55 years old) with CVUs in lower extremities, we investigated the correlation between AI distribution in CVUs and the histopathological changes, mainly proliferative and vascular changes. Our results show a distinct spatial distribution of AI along the ulcer in the epidermis and in the dermis with the highest level of expression being at the ulcer edge and the least expression towards the ulcer base. The AI cellular immunoreactivity, enzymatic activity, and protein levels were significantly increased towards the ulcer edge. Interestingly, a similar pattern of expression was encountered in the proliferative and the vascular changes with strong correlations between AI and the proliferative activity and vascular changes. Furthermore, AI cellular distribution was associated with increased proliferative activity, inflammation, and vascular changes. Our findings of differential expression of AI along the CVU base, edge, and nearby surrounding skin and its associations with increased proliferative activity and vascular changes provide further support to the AI implication in CVU pathogenesis. The presence of high levels of AI in the epidermis of chronic wounds may serve as a molecular marker of impaired healing and may provide future targets for therapeutic intervention.
- Open Access
- 25 May 2020
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 14, 530
Cutaneous Aβ-Non-nociceptive, but Not C-Nociceptive, Dorsal Root Ganglion Neurons Exhibit Spontaneous Activity in the Streptozotocin Rat Model of Painful Diabetic Neuropathy in vivo
Diabetic peripheral neuropathic pain (DPNP) is the most devastating complication of diabetes mellitus. Unfortunately, successful therapy for DPNP remains a challenge because its pathogenesis is still elusive. However, DPNP is believed to be due partly to abnormal hyperexcitability of dorsal root ganglion (DRG) neurons, but the relative contributions of specific functional subtypes remain largely unknown. Here, using the strepotozotocin (STZ) rat model of DPNP induced by a STZ injection (60 mg/kg, i.p), and intracellular recordings of action potentials (APs) from DRG neurons in anesthetized rats, we examined electrophysiological changes in C-and Aβ-nociceptive and Aβ-low threshold mechanoreceptive (LTM) neurons that may contribute to DPNP. Compared with control, we found in STZ-rats with established pain hypersensitivity (5 weeks post-STZ) several significant changes including: (a) A 23% increase in the incidence of spontaneous activity (SA) in Aβ-LTMs (but not C-mechanosensitive nociceptors) that may cause dysesthesias/paresthesia suffered by DPNP patients, (b) membrane hyperpolarization and a ∼85% reduction in SA rate in Aβ-LTMs by Kv7 channel activation with retigabine (6 mg/kg, i.v.) suggesting that Kv7/M channels may be involved in mechanisms of SA generation in Aβ-LTMs, (c) decreases in AP duration and in duration and amplitude of afterhyperpolarization (AHP) in C-and/or Aβ-nociceptors. These faster AP and AHP kinetics may lead to repetitive firing and an increase in afferent input to the CNS and thereby contribute to DPNP development, and (d) a decrease in the electrical thresholds of Aβ-nociceptors that may contribute to their sensitization, and thus to the resulting hypersensitivity associated with DPNP.
- 25 May 2020
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 14, 530
Open AccessCutaneous Aβ-Non-nociceptive, but Not C-Nociceptive, Dorsal Root Ganglion Neurons Exhibit Spontaneous Activity in the Streptozotocin Rat Model of Painful Diabetic Neuropathy in vivo
Diabetic peripheral neuropathic pain (DPNP) is the most devastating complication of diabetes mellitus. Unfortunately, successful therapy for DPNP remains a challenge because its pathogenesis is still elusive. However, DPNP is believed to be due partly to abnormal hyperexcitability of dorsal root ganglion (DRG) neurons, but the relative contributions of specific functional subtypes remain largely unknown. Here, using the strepotozotocin (STZ) rat model of DPNP induced by a STZ injection (60 mg/kg, i.p), and intracellular recordings of action potentials (APs) from DRG neurons in anesthetized rats, we examined electrophysiological changes in C-and Aβ-nociceptive and Aβ-low threshold mechanoreceptive (LTM) neurons that may contribute to DPNP. Compared with control, we found in STZ-rats with established pain hypersensitivity (5 weeks post-STZ) several significant changes including: (a) A 23% increase in the incidence of spontaneous activity (SA) in Aβ-LTMs (but not C-mechanosensitive nociceptors) that may cause dysesthesias/paresthesia suffered by DPNP patients, (b) membrane hyperpolarization and a ∼85% reduction in SA rate in Aβ-LTMs by Kv7 channel activation with retigabine (6 mg/kg, i.v.) suggesting that Kv7/M channels may be involved in mechanisms of SA generation in Aβ-LTMs, (c) decreases in AP duration and in duration and amplitude of afterhyperpolarization (AHP) in C-and/or Aβ-nociceptors. These faster AP and AHP kinetics may lead to repetitive firing and an increase in afferent input to the CNS and thereby contribute to DPNP development, and (d) a decrease in the electrical thresholds of Aβ-nociceptors that may contribute to their sensitization, and thus to the resulting hypersensitivity associated with DPNP.